<i>ortho-</i>Directing Chromium Arene Complexes as Efficient Mediators for Enantiospecific C(sp²)–C(sp³) Cross-Coupling Reactions

<p>Supplemental material, supplementary_table_6 for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9 by Dong-qin Chen, Chen Yu, Xue-feng Zhang, Zhong-fang Liu, Rui Wang, Min Jiang, Hao Chen, Feng Yan, Min Tao, Long-bang Chen, Hong Zhu and Ji-feng Feng in Therapeutic Advances in Medical Oncology</p

supplementary_table_2_(1) – Supplemental material for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9

<p>Supplemental material, supplementary_table_2_(1) for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9 by Dong-qin Chen, Chen Yu, Xue-feng Zhang, Zhong-fang Liu, Rui Wang, Min Jiang, Hao Chen, Feng Yan, Min Tao, Long-bang Chen, Hong Zhu and Ji-feng Feng in Therapeutic Advances in Medical Oncology</p

Supplementary-Fig._S4_(1)_pdf – Supplemental material for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9

<p>Supplemental material, Supplementary-Fig._S4_(1)_pdf for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9 by Dong-qin Chen, Chen Yu, Xue-feng Zhang, Zhong-fang Liu, Rui Wang, Min Jiang, Hao Chen, Feng Yan, Min Tao, Long-bang Chen, Hong Zhu and Ji-feng Feng in Therapeutic Advances in Medical Oncology</p

supplementary_table_7_(1) – Supplemental material for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9

<p>Supplemental material, supplementary_table_7_(1) for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9 by Dong-qin Chen, Chen Yu, Xue-feng Zhang, Zhong-fang Liu, Rui Wang, Min Jiang, Hao Chen, Feng Yan, Min Tao, Long-bang Chen, Hong Zhu and Ji-feng Feng in Therapeutic Advances in Medical Oncology</p

Supplementary-Fig._S2_pdf – Supplemental material for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9

<p>Supplemental material, Supplementary-Fig._S2_pdf for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9 by Dong-qin Chen, Chen Yu, Xue-feng Zhang, Zhong-fang Liu, Rui Wang, Min Jiang, Hao Chen, Feng Yan, Min Tao, Long-bang Chen, Hong Zhu and Ji-feng Feng in Therapeutic Advances in Medical Oncology</p

Supplementary-Fig._S3_pdf – Supplemental material for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9

<p>Supplemental material, Supplementary-Fig._S3_pdf for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9 by Dong-qin Chen, Chen Yu, Xue-feng Zhang, Zhong-fang Liu, Rui Wang, Min Jiang, Hao Chen, Feng Yan, Min Tao, Long-bang Chen, Hong Zhu and Ji-feng Feng in Therapeutic Advances in Medical Oncology</p

supplementary_table_4_(2) – Supplemental material for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9

<p>Supplemental material, supplementary_table_4_(2) for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9 by Dong-qin Chen, Chen Yu, Xue-feng Zhang, Zhong-fang Liu, Rui Wang, Min Jiang, Hao Chen, Feng Yan, Min Tao, Long-bang Chen, Hong Zhu and Ji-feng Feng in Therapeutic Advances in Medical Oncology</p

supplementary_table_1_(1) – Supplemental material for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9

<p>Supplemental material, supplementary_table_1_(1) for HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9 by Dong-qin Chen, Chen Yu, Xue-feng Zhang, Zhong-fang Liu, Rui Wang, Min Jiang, Hao Chen, Feng Yan, Min Tao, Long-bang Chen, Hong Zhu and Ji-feng Feng in Therapeutic Advances in Medical Oncology</p